ASPIRE trial explores survival benefits of adding chemotherapy to standard prostate cancer treatment
The Alliance for Clinical Trials in Oncology is now enrolling patients in the ASPIRE trial (A032302)-a large-scale, phase III ...
About 1 in 8 men will be diagnosed with prostate cancer in their lifetime The average age at diagnosis is 67 Less than 1% of the 3.5 million men living with prostate cancer are expected to die from it ...
The Times of Israel on MSN
Netanyahu reveals prostate cancer treatment, which he underwent without informing public
Malignant tumor found months ago successfully treated with radiation therapy, doctor says; PM, 76, says he withheld diagnosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results